- Slide show Pancreatic Cancer : Highlights from the 42 nd Annual Meeting of the American Society of Clinical Oncology , 2006

@inproceedings{Saif2007SS,
  title={- Slide show Pancreatic Cancer : Highlights from the 42 nd Annual Meeting of the American Society of Clinical Oncology , 2006},
  author={Muhammad Wasif Saif},
  year={2007}
}
Despite advances in our understanding of the molecular and genetic basis of pancreatic cancer, the disease remains a clinical challenge. Gemcitabine, the standard chemotherapy for pancreatic cancer, offers modest improvement of tumor-related symptoms and marginal advantage of survival. New approaches, alone and in combination with gemcitabine, are being developed to combat this cancer. Combination chemotherapy trials incorporating gemcitabine, cisplatin, 5fluorouracil, oxaliplatin, or… CONTINUE READING